Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 How Should We Regard Information Gathered in Nazi Experiments? Arthur L. Caplan, PhD Immorally acquired information, from Nazi experimentation or other sources, infects the body of scientific and biomedical knowledge. AMA J Ethics. 2021;23(1):E55-58. doi: 10.1001/amajethics.2021.55. State of the Art and Science Oct 2020 Using OCAP and IQ as Frameworks to Address a History of Trauma in Indigenous Health Research Angela Mashford-Pringle, PhD and Kira Pavagadhi, MPH Researchers and scholars should co-develop research with Indigenous peoples to ensure respect for culture, language, and ways of knowing. AMA J Ethics. 2020;22(10):E868-873. doi: 10.1001/amajethics.2020.868. State of the Art and Science Jan 2020 Making Emergency Use of Experimental Vaccines Safer Archana Asundi, MD and Nahid Bhadelia, MD How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”? AMA J Ethics. 2020;22(1):E43-49. doi: 10.1001/amajethics.2020.43. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396. Health Law May 2022 ¿La regulación de suplementos dietéticos como alimentos promueve la seguridad pública en un mundo de influentes en redes sociales? Joshua Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences. AMA J Ethics. 2022;E396-401. doi: 10.1001/amajethics.2022.396. State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762. State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. State of the Art and Science May 2018 Defining “Community” and “Consultation” for Emergency Research that Requires an Exception from Informed Consent Samuel A. Tisherman, MD Emergency research that requires exception from informed consent presents challenges in defining and reaching the at-risk community. AMA J Ethics. 2018;20(5):467-474. doi: 10.1001/journalofethics.2018.20.5.stas1-1805. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
State of the Art and Science Jan 2021 How Should We Regard Information Gathered in Nazi Experiments? Arthur L. Caplan, PhD Immorally acquired information, from Nazi experimentation or other sources, infects the body of scientific and biomedical knowledge. AMA J Ethics. 2021;23(1):E55-58. doi: 10.1001/amajethics.2021.55.
State of the Art and Science Oct 2020 Using OCAP and IQ as Frameworks to Address a History of Trauma in Indigenous Health Research Angela Mashford-Pringle, PhD and Kira Pavagadhi, MPH Researchers and scholars should co-develop research with Indigenous peoples to ensure respect for culture, language, and ways of knowing. AMA J Ethics. 2020;22(10):E868-873. doi: 10.1001/amajethics.2020.868.
State of the Art and Science Jan 2020 Making Emergency Use of Experimental Vaccines Safer Archana Asundi, MD and Nahid Bhadelia, MD How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”? AMA J Ethics. 2020;22(1):E43-49. doi: 10.1001/amajethics.2020.43.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396.
Health Law May 2022 ¿La regulación de suplementos dietéticos como alimentos promueve la seguridad pública en un mundo de influentes en redes sociales? Joshua Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences. AMA J Ethics. 2022;E396-401. doi: 10.1001/amajethics.2022.396.
State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
State of the Art and Science May 2018 Defining “Community” and “Consultation” for Emergency Research that Requires an Exception from Informed Consent Samuel A. Tisherman, MD Emergency research that requires exception from informed consent presents challenges in defining and reaching the at-risk community. AMA J Ethics. 2018;20(5):467-474. doi: 10.1001/journalofethics.2018.20.5.stas1-1805.